Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

SHA:603882 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,177	2,434	2,458	2,929	2,653	1,635
Cash & Short-Term Investments	2,177	2,434	2,458	2,929	2,653	1,635
Cash Growth	21.36%	-0.98%	-16.08%	10.37%	62.26%	71.25%
Accounts Receivable	4,141	4,429	5,399	7,136	4,804	2,771
Other Receivables	78.72	82.71	76.98	91.65	66.1	54.86
Receivables	4,220	4,512	5,476	7,227	4,870	2,826
Inventory	190.72	198.32	248.21	405.25	345.14	238.13
Prepaid Expenses	39.3	38.44	47.43	48.94	43	43.01
Other Current Assets	77.53	136.02	35.5	49.49	18.74	19.09
Total Current Assets	6,705	7,318	8,265	10,660	7,930	4,762
Property, Plant & Equipment	1,932	1,968	2,305	2,215	1,968	1,225
Long-Term Investments	458.15	425.03	554.25	353.63	358.32	235.19
Goodwill	52.21	52.21	52.21	32.68	13.35	13.35
Other Intangible Assets	163.63	167.54	150.33	152	68.41	138.63
Long-Term Deferred Tax Assets	287.07	241.42	151.11	86.34	36.11	15.47
Long-Term Deferred Charges	151.17	184.74	245.24	255.19	197.69	176.87
Other Long-Term Assets	34.72	34.28	44.15	137.95	179.11	73.23
Total Assets	9,784	10,392	11,768	13,893	10,751	6,639
Accounts Payable	1,693	1,716	2,065	2,988	2,283	1,627
Accrued Expenses	195.92	260.1	355.61	995.92	834.42	251.61
Short-Term Debt	-	1	1	-	-	37.17
Current Portion of Long-Term Debt	98.74	37.82	14.83	137.66	130.93	-
Current Portion of Leases	55.04	76.25	115.51	84	70.04	-
Current Income Taxes Payable	25.57	59.16	15.49	231.97	228.13	101.13
Current Unearned Revenue	63.44	54.84	76.78	104.62	131.8	93.06
Other Current Liabilities	40.91	27.1	44.82	38	50.03	201.93
Total Current Liabilities	2,173	2,232	2,689	4,580	3,728	2,311
Long-Term Debt	509.03	514.93	267.61	143	248.74	379.19
Long-Term Leases	109.5	118.39	180.26	203.63	172.39	-
Long-Term Unearned Revenue	18.7	22.38	24.97	24.42	37.45	52.88
Long-Term Deferred Tax Liabilities	25.51	28.71	58.26	64.4	41.63	19.22
Total Liabilities	2,835	2,917	3,220	5,016	4,228	2,763
Common Stock	463.26	463.26	468.77	467.14	465.59	459.49
Additional Paid-In Capital	1,171	1,171	1,515	1,517	1,377	923.89
Retained Earnings	5,162	5,654	6,443	6,632	4,473	2,406
Treasury Stock	-	-	-89.99	-	-	-
Comprehensive Income & Other	28.39	36.66	26.03	18.04	-11.76	-1.76
Total Common Equity	6,825	7,325	8,363	8,633	6,304	3,787
Minority Interest	123.54	149.8	184.56	243.4	218.78	89.37
Shareholders' Equity	6,948	7,475	8,547	8,877	6,523	3,877
Total Liabilities & Equity	9,784	10,392	11,768	13,893	10,751	6,639
Total Debt	772.32	748.39	579.21	568.3	622.1	416.36
Net Cash (Debt)	1,405	1,685	1,878	2,360	2,031	1,219
Net Cash Growth	28.73%	-10.29%	-20.42%	16.20%	66.65%	258.22%
Net Cash Per Share	3.02	3.62	4.03	5.06	4.36	2.64
Filing Date Shares Outstanding	463.26	463.26	464.79	467.3	465.59	459.49
Total Common Shares Outstanding	463.26	463.26	468.12	467.14	465.59	459.49
Working Capital	4,532	5,086	5,576	6,079	4,202	2,450
Book Value Per Share	14.73	15.81	17.86	18.48	13.54	8.24
Tangible Book Value	6,609	7,106	8,160	8,449	6,222	3,635
Tangible Book Value Per Share	14.27	15.34	17.43	18.09	13.36	7.91
Buildings	752.98	748.83	658.02	577.61	570.99	570.99
Machinery	2,497	2,503	2,945	2,748	2,237	1,582
Construction In Progress	629	527.95	359.11	205.53	143.15	17.73

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.